[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:calr-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"CALR Gene",7,6,[8,16,22,28,34,41,47],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06034002","A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms",[12],"Phase 1","RECRUITING","2026-08-26T02:18:51.009190Z","2026-05-05T02:43:28.650417Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07008118","A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms",[12],"2026-08-26T02:18:09.641312Z","2026-05-05T02:43:27.965447Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06150157","A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms",[12],"2026-08-26T02:16:23.080181Z","2026-04-29T02:57:57.158454Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT05025488","Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm",[12],"2026-08-26T02:15:23.202838Z","2026-05-05T02:43:29.683710Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":39,"content_modified":40},"NCT07032727","Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations",[38],"Phase 2","2026-08-26T02:15:38.131683Z","2026-05-05T02:43:28.209956Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06480591","Evaluation of the Pathobiology of CALR-mutated MPN Cells",[],"2026-08-26T02:17:18.747857Z","2026-05-13T02:55:06.494166Z",{"nct_id":48,"title":49,"phases":50,"status":51,"updated_at":52,"content_modified":53},"NCT07521046","Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis)",[12],"NOT_YET_RECRUITING","2026-08-26T02:18:22.309547Z","2026-05-05T02:43:27.418283Z"]